Unicycive Therapeutics, Inc. (UNCY)
5.205
+0.16
(+3.07%)
USD |
NASDAQ |
Sep 02, 16:00
5.205
0.00 (0.00%)
After-Hours: 16:51
Unicycive Therapeutics Research and Development Expense (Annual) : 9.121M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 9.121M |
| December 31, 2024 | 20.01M |
| December 31, 2023 | 12.90M |
| December 31, 2022 | 12.44M |
| Date | Value |
|---|---|
| December 31, 2021 | 6.08M |
| December 31, 2020 | 1.015M |
| December 31, 2019 | 0.795M |
| December 31, 2018 | 0.344M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Theriva Biologics, Inc. | 8.604M |
| AbbVie, Inc. | 8.249B |
| Decoy Therapeutics, Inc. | 0.3682M |
| Nkarta, Inc. | 81.24M |